Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Vonoprazan Dual Therapy	349
Overall Study	STARTED	Vonoprazan Triple Therapy	349
Overall Study	STARTED	Lansoprazole Triple Therapy	348
Overall Study	Received Study Drugs	Vonoprazan Dual Therapy	348
Overall Study	Received Study Drugs	Vonoprazan Triple Therapy	346
Overall Study	Received Study Drugs	Lansoprazole Triple Therapy	345
Overall Study	COMPLETED	Vonoprazan Dual Therapy	334
Overall Study	COMPLETED	Vonoprazan Triple Therapy	331
Overall Study	COMPLETED	Lansoprazole Triple Therapy	334
Overall Study	NOT COMPLETED	Vonoprazan Dual Therapy	15
Overall Study	NOT COMPLETED	Vonoprazan Triple Therapy	18
Overall Study	NOT COMPLETED	Lansoprazole Triple Therapy	14

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04167670/flow